Abstract
Microarray-based techniques allow us to visualize and quantify the expression of every single gene in any population of cells. In yeast the true potential of large-scale transcriptome analysis in identifying regulatory units and understanding gene function has already been demonstrated by evaluating expression profiles of a comprehensive group of mutants. We discuss the potential of DNA-chip technologies for the analysis of gene expression in complex organisms. The usefulness of transcriptome analysis for clinical purposes und diagnosis of cancers is already well established. We argue that microarray-based expression profiling will also be a useful tool for the analysis of gene function and approaches complementary to classical phenotypic description in mammals, particularly in regard of the large resources of mutant models that are currently being generated by gene-targeting and mutagenesis of the mouse genome. Experimental requirements and potential future directions are discussed.
Keywords: dna-chip technology, transcriptome analysis, gene expression
Current Genomics
Title: Molecular Phenotyping of Mouse Mutant Resources by RNA Expression Profiling
Volume: 3 Issue: 3
Author(s): J. Beckers, J. Hoheisel, W. Mewes, M. Vingron and M. Hrabe de Angelis
Affiliation:
Keywords: dna-chip technology, transcriptome analysis, gene expression
Abstract: Microarray-based techniques allow us to visualize and quantify the expression of every single gene in any population of cells. In yeast the true potential of large-scale transcriptome analysis in identifying regulatory units and understanding gene function has already been demonstrated by evaluating expression profiles of a comprehensive group of mutants. We discuss the potential of DNA-chip technologies for the analysis of gene expression in complex organisms. The usefulness of transcriptome analysis for clinical purposes und diagnosis of cancers is already well established. We argue that microarray-based expression profiling will also be a useful tool for the analysis of gene function and approaches complementary to classical phenotypic description in mammals, particularly in regard of the large resources of mutant models that are currently being generated by gene-targeting and mutagenesis of the mouse genome. Experimental requirements and potential future directions are discussed.
Export Options
About this article
Cite this article as:
Beckers J., Hoheisel J., Mewes W., Vingron M. and de Angelis Hrabe M., Molecular Phenotyping of Mouse Mutant Resources by RNA Expression Profiling, Current Genomics 2002; 3 (3) . https://dx.doi.org/10.2174/1389202023350453
DOI https://dx.doi.org/10.2174/1389202023350453 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases
Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of ...read more
Integrating Machine Learning with Genome Science: Pioneering Developments and Future Directions
Integrating machine learning (ML) with genome science is driving transformative advancements in fields such as genomics, personalized medicine, and drug discovery. Genomic data is vast and complex, making traditional analysis methods inadequate for uncovering deep insights. Machine learning, particularly deep learning models like convolutional neural networks (CNNs) and recurrent neural ...read more
Related Journals
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Internal Ribosome Entry Site Elements in Eukaryotic Genomes
Current Genomics Medical Chemistry to Spy Cancer Stem Cells from Outside the Body
Mini-Reviews in Medicinal Chemistry Use of the Non-Toxic Cryoprotectant Trehalose Enhances Recovery and Function of Fish Embryonic Stem Cells Following Cryogenic Storage
Current Stem Cell Research & Therapy Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders
Current Drug Targets Indazole Derivatives: Promising Anti-tumor Agents
Anti-Cancer Agents in Medicinal Chemistry ADAM Metalloproteinases as Potential Drug Targets
Current Medicinal Chemistry “Non-Taxifolin” Derived Flavonolignans: Phytochemistry and Biology
Current Pharmaceutical Design Non-Transferrin Bound Iron - Determination in Biological Material and Clinical Implications
Current Pharmaceutical Analysis Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems
Current Pharmaceutical Biotechnology Modulation of TRAIL-Induced Apoptosis by HDAC Inhibitors
Current Cancer Drug Targets Evolving Strategies for the Treatment of T-Cell Lymphoma: A Systematic Review and Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Notch-Associated MicroRNAs in Cancer
Current Drug Targets Cytotoxic Activity of Polysubstituted 7-chloro-4-quinolinylhydrazone Derivatives
Letters in Drug Design & Discovery Restoring TRAIL Induced Apoptosis Using Naturopathy. Hercules Joins Hand with Nature to Triumph Over Lernaean Hydra
Current Genomics Differential Involvement of Myosin II and VI in the Spontaneous and SDF- 1-induced Migration of Adult CD133+ Hematopoietic Stem/Progenitor Cells and Leukemic Cells
Current Cancer Therapy Reviews Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable
Current Cancer Therapy Reviews Pyridine Based Antitumour Compounds Acting at the Colchicine Site
Current Medicinal Chemistry Molecular Targets for the Treatment of Multiple Myeloma
Current Cancer Drug Targets Role of Hsp70 in Cancer Growth and Survival
Protein & Peptide Letters Myelodysplastic Syndromes: Review of Pathophysiology and Current Novel Treatment Approaches
Current Cancer Drug Targets